Effects of Gene-Transfected Bone Marrow-Derived Liver Stem Cells Transplantation on Liver Fibrosis in Rats

ZONG Chun-hua,SUN Chao,WANG Bao-can,CHEN Yuan-wen,CHEN Ying-wei,SUN Qiao-ling,LI Ding-guo
DOI: https://doi.org/10.3969/j.issn.1674-8115.2007.04.002
2007-01-01
Abstract:Objective To explore the effects of urokinase type plasminogen activator(uPA) gene-modified bone marrow-derived stem cells(BDLSCs) transplantation on CCl4-induced liver fibrosis in rats. Methods BDLSCs were selected and amplified by setting up cholestatic hepatic injured model and preparing a pathological conditioned medium containing 5% cholestatic serum.RT-PCR method was applied to determine the expression of characteristics of liver stem cells.BDLSCs were transfected by AduPA in vitro and transplanted into rats with CCl4-induced liver fibrosis.Liver functions,areas of collagen and pathohistology were observed. Results Bone marrow cells were able to form hepatocyte-like colonies in the presence of pathological conditioned medium,and express characteristical proteins of fetal hepatocytes.Studies in vivo showed that in the BDLSC-uPA group the serum levels of alanine aminotransferase(ALT),alkaline phosphatase(AKP) and total bilirubin(TBIL) decreased dramatically,prothrombin time(PT) shortened,the serum albumin level(ALB) was higher,and serum levels of extracellular matrix(ECM) and hydroxyproline(Hyp) content of the liver were much lower,the extent of the fibrotic tissues of the liver was much less,and the formation of pseudolobules were not obvious,the areas of collagen were markedly smaller,compared with those in the control group of rats infused by normal saline and BDLSCs. Conclusion uPA gene-modified BDLSCs transplantation may suppress hepatic fibrosis and ameliorate liver functions in fibrotic rats induced by CCl4 injection,which provides theoretical basis and practical foundation for the clinical application of gene-modified BDLSCs in treating liver fibrosis.
What problem does this paper attempt to address?